Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helge Frieling

Showing results (151-160 of 209) with videos related to

Pageof 21
Sort By:
Psychoneuroendocrinology|August 16, 2021
Differences in the promoter methylation of atrial natriuretic peptide and vasopressin in alcohol use disorder. A longitudinal case-control-study during withdrawal therapyPhileas Johannes Proskynitopoulos, Mathias Rhein, Lasse Per Petersson, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 25, 2020
Electroconvulsive therapy, changes in immune cell ratios, and their association with seizure quality and clinical outcome in depressed patientsNicole Moschny, Kirsten Jahn, Hannah Benedictine Maier, et al.
European Addiction Research|December 11, 2017
Epigenetic Regulation of the Promotor Region of Vascular Endothelial Growth Factor-A and Nerve Growth Factor in Opioid-Maintained PatientsAdrian Groh, Kirsten Jahn, Alexandra Burkert, et al.
Alcoholism, Clinical and Experimental Research|April 17, 2007
Role of appetite-regulating peptides in alcohol craving: an analysis in respect to subtypes and different consumption patterns in alcoholismThomas Hillemacher, Thomas Kraus, Johannes Rauh, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|April 22, 2017
Joint Effects of the Epigenetic Alteration of Neurotrophins and Cytokine Signaling: A Possible Exploratory Model of Affective Symptoms in Alcohol-Dependent Patients?Annemarie Heberlein, Rilana Schuster, Alexandra Kleimann, et al.
The Analyst|March 29, 2012
Stable-isotope dilution GC-MS method for ethanol in vapour ethanol and microdialysis systems based on carbonate-catalyzed extractive pentafluorobenzoylationMani Haschemi Nassab, Anja Mitschke, Maria-Theresia Suchy, et al.
Physiology & Behavior|November 20, 2022
The androgen system across the menstrual cycle: Hormonal, (epi-)genetic and psychometric alterationsTillmann H C Krüger, Brigitte Leeners, Enrico Tronci, et al.
Translational Psychiatry|January 23, 2018
P11 promoter methylation predicts the antidepressant effect of electroconvulsive therapyAlexandra Neyazi, Wiebke Theilmann, Claudia Brandt, et al.
Translational Psychiatry|June 10, 2022
Distinct promoter regions of the oxytocin receptor gene are hypomethylated in Prader-Willi syndrome and in Prader-Willi syndrome associated psychosisHannah M Heseding, Kirsten Jahn, Christian K Eberlein, et al.
Clinical Epigenetics|July 31, 2020
Novel candidate genes for ECT response prediction-a pilot study analyzing the DNA methylome of depressed patients receiving electroconvulsive therapyNicole Moschny, Tristan Zindler, Kirsten Jahn, et al.
Pageof 21

Showing results (151-160 of 209) with videos related to

Sort By:
Pageof 21
Psychoneuroendocrinology|August 16, 2021
Differences in the promoter methylation of atrial natriuretic peptide and vasopressin in alcohol use disorder. A longitudinal case-control-study during withdrawal therapyPhileas Johannes Proskynitopoulos, Mathias Rhein, Lasse Per Petersson, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 25, 2020
Electroconvulsive therapy, changes in immune cell ratios, and their association with seizure quality and clinical outcome in depressed patientsNicole Moschny, Kirsten Jahn, Hannah Benedictine Maier, et al.
European Addiction Research|December 11, 2017
Epigenetic Regulation of the Promotor Region of Vascular Endothelial Growth Factor-A and Nerve Growth Factor in Opioid-Maintained PatientsAdrian Groh, Kirsten Jahn, Alexandra Burkert, et al.
Alcoholism, Clinical and Experimental Research|April 17, 2007
Role of appetite-regulating peptides in alcohol craving: an analysis in respect to subtypes and different consumption patterns in alcoholismThomas Hillemacher, Thomas Kraus, Johannes Rauh, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|April 22, 2017
Joint Effects of the Epigenetic Alteration of Neurotrophins and Cytokine Signaling: A Possible Exploratory Model of Affective Symptoms in Alcohol-Dependent Patients?Annemarie Heberlein, Rilana Schuster, Alexandra Kleimann, et al.
The Analyst|March 29, 2012
Stable-isotope dilution GC-MS method for ethanol in vapour ethanol and microdialysis systems based on carbonate-catalyzed extractive pentafluorobenzoylationMani Haschemi Nassab, Anja Mitschke, Maria-Theresia Suchy, et al.
Physiology & Behavior|November 20, 2022
The androgen system across the menstrual cycle: Hormonal, (epi-)genetic and psychometric alterationsTillmann H C Krüger, Brigitte Leeners, Enrico Tronci, et al.
Translational Psychiatry|January 23, 2018
P11 promoter methylation predicts the antidepressant effect of electroconvulsive therapyAlexandra Neyazi, Wiebke Theilmann, Claudia Brandt, et al.
Translational Psychiatry|June 10, 2022
Distinct promoter regions of the oxytocin receptor gene are hypomethylated in Prader-Willi syndrome and in Prader-Willi syndrome associated psychosisHannah M Heseding, Kirsten Jahn, Christian K Eberlein, et al.
Clinical Epigenetics|July 31, 2020
Novel candidate genes for ECT response prediction-a pilot study analyzing the DNA methylome of depressed patients receiving electroconvulsive therapyNicole Moschny, Tristan Zindler, Kirsten Jahn, et al.
Pageof 21